Surface-immobilized antimicrobial peptoids

US10676509B2 · US · B2

Patent metadata
FieldValue
Publication numberUS-10676509-B2
Application numberUS-53387609-A
CountryUS
Kind codeB2
Filing dateJul 31, 2009
Priority dateJul 31, 2008
Publication dateJun 9, 2020
Grant dateJun 9, 2020

How to read this patent

A practical reading order for non-experts. Skip the full description unless you need deep technical detail.

  1. Title

    What the patent document calls the invention.

  2. Abstract

    A short plain-language summary of the technical disclosure.

  3. Assignees and inventors

    Who owns or filed the patent and who is credited as inventor.

  4. Key dates

    Filing, priority, publication, and grant dates set the timeline.

  5. First independent claim

    The legal scope of protection — read this for what is actually claimed.

  6. CPC / IPC classifications

    Technology tags used to group this patent with similar filings.

  7. Citations and related patents

    Prior art links and similar publications in this corpus.

Abstract

Official abstract text for this publication.

Immobilizable antimicrobial compounds incorporating antimicrobial and/or antifouling components, as can be adhered to various device structures and components.

First claim

Opening claim text (preview).

We claim: 1. An antimicrobial compound comprising an ampetoid component, wherein the ampetoid component comprises a trimer of a formula —(—X—Y—Z)— n , wherein X, Y, and Z are independently selected monomeric residues, wherein each monomeric residue is independently selected from proline residues and N-substituted glycine residues, wherein the N-substituents are independently selected from about C 4 - about C 20 linear, branched and cyclic alkyl moieties, α-amino acid side chain moieties and carbon homologs thereof, provided the ampetoid component is amphipathic and has a net positive charge under physiological conditions, an anchor component, wherein the anchor component comprises at least two DOPA residues and a lysine residue, an anti-fouling component, wherein the anti-fouling component comprises at least one N-methoxyethylglycine (N me ) residue, wherein the anti-fouling component couples the ampetoid component and the anchor component, wherein the antimicrobial compound comprises a formula A-(-X—Y—Z—)— n —B—(—N me —) n′ -(-DOPA-Lys-) n″ -DOPA-NH 2 wherein A is selected from H and a terminal N-alkyl substituted glycine residue, N R , wherein R is selected from C 4 -C 20 linear, branched and cyclic alkyl moieties, wherein in the trimer —(—X—Y—Z—)— n , X is selected from an N-(4-(aminobutyl)glycine (N Lys ) residue, at least one of Y and Z is selected from N-(phenylmethyl)glycine (N pm ), (R)—N-(1-phenylethyl)glycine (N gpe ), and (S)—N-(1-phenylethyl)glycine (N spe ) residues, and n is an integer selected from the group consisting of 1-5, wherein B is selected from a covalent bond, an N Lys residue and N Lys -N spe residues, wherein n′ is an integer selected from the group consisting of 10-25, and wherein n″ is an integer selected from the group consisting of 1-5. 2. The compound of claim 1 wherein A is H; and n is 3-4. 3. The compound of claim 2 wherein n is 3; and B is N Lys -N spe residues, said ampetoid component of a formula H—(—N Lys -N spe —N spe —)—N Lys -N spe . 4. The compound of claim 2 wherein n is 4; and B is selected from a covalent bond and an N Lys residue, said ampetoid component of a formula H—(—N Lys —N spe —N spe ) 4 or H—(—N Lys —N spe —N spe —)— 4 N Lys . 5. The compound of claim 1 wherein said ampetoid component is of a formula H—(—N Lys —N spe —N spe —N Lys —N spe -L-Pro-(-N Lys —N spe —N spe ) 2 . 6. The compound of claim 2 wherein A is a terminal N-alkyl substituted glycine residue, said alkyl substituent R selected from about C 6 to about C 18 linear alkyl moieties; B is a covalent bond; and n is selected from 1 and 2. 7. The compound of claim 2 wherein A is a terminal N-alkyl substituted glycine residue, said alkyl substituent R selected from about C 6 to about C 18 linear, branched and cyclic alkyl moieties; B is an N Lys residue; and n is 1. 8. The compound of claim 7 wherein said ampetoid component is of a formula H—N tridec —N Lys —N spe —N spe —N Lys . 9. An article of manufacture comprising a metal substrate and a coating coupled thereto, said coating comprising an antimicrobial compound selected from compounds of claim 1 . 10. The article of claim 9 wherein said anchor component comprises a (DOPA-Lys) 2 -DOPA sequence of residues. 11. The article of claim 9 wherein said substrate is a medical device. 12. The article of claim 11 wherein said substrate comprises titanium oxide. 13. An antimicrobial compound of a formula H—N Lys —N spe —N spe —N Lys —N spe -L-Pro-(N Lys —N spe —N spe ) 2 —(N me ) 20 -(DOPA- Lys ) 2 -DOPA- NH 2 .

Assignees

Inventors

Classifications

  • by chemical synthesis · CPC title

  • Macromolecular compounds · CPC title

  • having 5 to 11 amino acids · CPC title

  • by giving articles subject to fouling a special shape or arrangement · CPC title

  • Paints containing biocides, e.g. fungicides, insecticides or pesticides (C09D5/16 takes precedence) · CPC title

Patent family

Related publications grouped by family.

External sources

Frequently asked questions

Answers are generated from the same data shown on this page.

What does patent US10676509B2 cover?
Immobilizable antimicrobial compounds incorporating antimicrobial and/or antifouling components, as can be adhered to various device structures and components.
Who is the assignee on this patent?
Messersmith Phillip B, Barron Annelise E, Statz Andrea, and 2 more
What technology area does this patent fall under?
Primary CPC classification C07K7/08. Mapped technology areas include Chemistry & Metallurgy.
When was this patent published?
Publication date Tue Jun 09 2020 00:00:00 GMT+0000 (Coordinated Universal Time) (B2). Legal status and post-grant events are not shown on this page.
What related patents are in patentsdb?
We list 8 related publications on this page (citations in our corpus or others sharing the same primary CPC).